Results 281 to 290 of about 94,931 (305)

Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C

American Journal of Ophthalmology, 2020
Matthew B Schlenker, Georges M Durr, Iqbal Ike K Ahmed   +2 more
exaly  

Controlled release of Mitomycin C from modified cellulose based thermo-gel prevents post-operative de novo peritoneal adhesion

Carbohydrate Polymers, 2020
Tamanna Sultana, Byong-Taek Lee
exaly  

Mitomycin C.

Cancer chemotherapy and biological response modifiers, 1992
N W, Gibson, D, Siegel, D, Ross
openaire   +1 more source

Ocular Toxicity of Mitomycin-C

International Ophthalmology Clinics, 1999
D R, Hardten, T W, Samuelson
openaire   +2 more sources

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Journal of Clinical Oncology, 2012
Jaffer A Ajani
exaly  

Mitomycin

Drugs, 2012
Dinesh Selva, Robert J Casson
exaly  

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

European Urology, 2016
Ottavio Chnio De Cobelli, Antoine G Van Der Heijden, Johannes Witjes   +2 more
exaly  

Mitomycin C

2005
openaire   +1 more source

Mitomycin C.

Cancer chemotherapy and biological response modifiers, 1995
N W, Gibson, R M, Phillips, D, Ross
openaire   +1 more source

Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial

Lancet Oncology, The, 2011
Savino M Di Stasi, Marco Valenti, Francesco Masedu   +2 more
exaly